Data from a phase 1/2 clinical trial of NRTX-1001 were presented at the ISSCR 2023 Annual Meeting.
International Society for Stem Cell Research (ISSCR)
Advertisement
Point-of-Care CAR T-Cell Therapy Yields 100% ORR in R/R CLL With or Without Richter’s Transformation
The phase 1/2 Euplagia-1 trial is currently ongoing in Europe.
Advertisement
